GT-TNF alpha-SLN 002

N/A

Report date: 2025/01/26 18:49:07
NME

Base Information

Drug NameGT-TNF alpha-SLN 002
Drug Alias NameTNF alpha siRNA therapy (Geneaty therapeutics)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionTumor necrosis factor inhibitors
TargetsTumor necrosis factor
Therapy Area/IndicationsArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGeneaty Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGeneaty Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsArthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A